Abbott Laboratories (ABT) released its fourth-quarter 2020 results on Wednesday, January 27, before trading opened. Sales growth exceeded Wall Street expectations in the diagnostics segment. Additionally, Abbott Laboratories claims to be a dividend aristocrat after the next dividend increase. Abbot Laboratories reported an increase in
The Coronavirus vaccine developed by Pfizer Inc. and BioNTech SE will provide 40 million doses to the COVAX vaccine distribution program, aiming to take COVID-19 vaccines to the world’s poorest countries. In a joint statement, the two pharmaceutical firms announced that distribution would start in
In recent weeks, the outbreak of coronavirus has led to new travel restriction initiatives in a number of U.S. states and cities, including California, New York and Chicago. The outbreak in the country reached the 12.9 million-case mark on Friday, and according to data from
The COVID-19 vaccine succeeds in the final stage trials while Pfizer agrees to make a $60 million equity investment in Homology. Shares of Pfizer, Inc. (PFE) soared up to 13% in the premarket following the update on the Phase 3 trials of the COVID-19 vaccine.
The strong preclinical results of Novan’s antiviral effect of nitric oxide-based medicine against SARS-CoV-2 puts the company in a place to develop an intranasal formulation of berdazimer sodium for use in coronavirus program. Shares of Novan Inc. (NOVN) has skyrocketed after the company today announced positive in vitro outcomes reflecting the potential efficacy of its NITRICIL™ platform technology as
Aclaris Therapeutics Inc [NASDAQ: ACRS] has been gaining quite strongly for the better part of October. This has everything to do with the company’s positioning in the fight against COVID-19. The company’s treatment called Aclaris ATI-450 has been found to be quite useful in the
© 2024, Powered by Smart TechOne
